{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:04:25Z","timestamp":1792843465369,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The unregulated drug supply in the United States is rapidly evolving, and veterinary tranquillisers have emerged as adulterants of concern, especially in illicitly\u2010manufactured fentanyl. Following the proliferation of xylazine, medetomidine, a more potent sedative, has recently appeared in multiple US states. This study describes the characteristics of medetomidine samples from a national mail\u2010based drug checking program and aims to determine whether medetomidine is associated with hallucinogenic effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of 11,363 drug samples between December 2022 and April 2025. Samples were sent voluntarily by people who use drugs. Participant\u2010reported sensations and sample characteristics (e.g., colour, texture) were gathered at point\u2010of\u2010contact. Composition was analysed using gas\u2010chromatography mass spectrometry. We estimated adjusted prevalence ratios for hallucinations in medetomidine\u2010containing samples using generalised estimating equations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Medetomidine was identified in 278 samples (2.4%), with pronounced growth beginning June 2024. Medetomidine commonly appeared with fentanyl (58.8%) and\/or xylazine (55.9%). Most samples were powders (85.3%). Among all 11,363 samples, those containing medetomidine in primary abundance (\n                      <jats:italic>n\u2009=<\/jats:italic>\n                      \u2009136) were more likely to be associated with reported hallucinations (17.6%) compared to all other samples (1.2%; adjusted prevalence ratio: 11.95, 95% confidence interval 6.36, 22.44).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions<\/jats:title>\n                    <jats:p>Medetomidine is an emerging adulterant, although its risk profile is under\u2010described. Our findings suggest medetomidine may cause hallucinogenic effects, contradicting clinical use for preventing delirium in postsurgical settings. Unexpected hallucinations may serve as a sentinel signal for medetomidine's presence in local drug markets. Education is needed for people who use drugs and clinicians about novel adverse effects of medetomidine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dar.70024","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:04:14Z","timestamp":1755857054000},"page":"1896-1906","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Emergence of Medetomidine in the Unregulated Drug Supply and Its Association With Hallucinogenic Effects"],"prefix":"10.1111","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5073-8677","authenticated-orcid":false,"given":"Adams L.","family":"Sibley","sequence":"first","affiliation":[{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madigan L.","family":"Bedard","sequence":"additional","affiliation":[{"name":"School of Medicine, Bowles Center for Alcohol Studies University of North Carolina at Chapel Hill  Chapel Hill USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-8950","authenticated-orcid":false,"given":"Samuel","family":"Tobias","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, Faculty of Medicine University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8902-2788","authenticated-orcid":false,"given":"Brooke A.","family":"Chidgey","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Anesthesiology University of North Carolina at Chapel Hill  Chapel Hill USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina G.","family":"Phillips","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Anesthesiology University of North Carolina at Chapel Hill  Chapel Hill USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bell","sequence":"additional","affiliation":[{"name":"Prevention Point Pittsburgh  Pittsburgh USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabarun","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Injury Prevention Research Center University of North Carolina at Chapel Hill  Chapel Hill USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology12020273"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.27550"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01211-z"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-015-9490-2"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32231-7"},{"issue":"8","key":"e_1_2_12_7_1","article-title":"Xylazine\u2010Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"Malayala S. V.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7037a4"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-011-9662-6"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.005"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7415a1"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.15242"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2001.11927725"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202500041"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addicn.2024.100155"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15992"},{"key":"e_1_2_12_17_1","article-title":"Illicit Medetomidine Use With Fentanyl","author":"Sood N.","year":"2025","journal-title":"Hospitalist"},{"key":"e_1_2_12_18_1","volume-title":"167 Contract No. 75F40122C00193: Understanding Overdose Through Scientific Innovation [Internet]","author":"Dasgupta N.","year":"2022"},{"key":"e_1_2_12_19_1","unstructured":"N.Dasgupta M.Figgatt M.Nocera andE.Tracy \u201cInstructions and Data Collection Card for Mail\u2010in Drug Checking \u201d2024 https:\/\/doi.org\/10.17615\/ewxr\u20101w86."},{"key":"e_1_2_12_20_1","unstructured":"UNC Street Drug Analysis Lab \u201cLab Methods & Attribution Text [Internet] \u201d2024 https:\/\/uncopioid.atlassian.net\/wiki\/external\/MzM2ODI4NGYzZmE4NDczNGIyZDNjZjE3NDc5NWFiMjU."},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202620"},{"key":"e_1_2_12_22_1","unstructured":"US Food and Drug Administration \u201cPRECEDEX (Dexmedetomidine Hydrochloride) Injection for Intravenous Use \u201d2024 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/021038Orig1s055lbl.pdf."},{"issue":"6","key":"e_1_2_12_23_1","article-title":"Dexmedetomidine in Prevention of Postoperative Delirium: A Systematic Review","volume":"14","author":"Fondeur J.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.10.022"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000951"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.10.026"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.03.098"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12680"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2001.62.616"},{"issue":"9","key":"e_1_2_12_30_1","first-page":"10","article-title":"Clonidine and Auditory Hallucinations","volume":"9","author":"Bestha D. P.","year":"2012","journal-title":"Innovations in Clinical Neuroscience"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-3-456"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.09.032"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200312000-00004"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000281"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1989.tb00290.x"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.03.005"},{"issue":"3","key":"e_1_2_12_37_1","first-page":"271","article-title":"Successful Treatment of Auditory Hallucinations in a Schizophrenia Patient With Clonidine","volume":"32","author":"Aksu M. H.","year":"2019","journal-title":"Dusunen Adam Journal of Psychiatry and Neurological Sciences"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-199609000-00030"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)38160-7"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.4253"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2024.2409720"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103128"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7415a2"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7415a3"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/87551225251326811"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T20:24:07Z","timestamp":1762201447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.70024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1111\/dar.70024"],"URL":"https:\/\/doi.org\/10.1111\/dar.70024","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"2025-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}